91 Results

People

  1. Lacouture
    Lacouture
  2. Saltz
    Saltz
  3. Halpern
    Halpern
  4. Miller
    Miller
  5. Myskowski
    Myskowski
  6. Dusza
    Dusza
  7. Hudis
    Hudis
  8. Kris
    Kris
  9. Motzer
    Motzer
  10. Norton
    Norton

Groups

  1. Department of Medicine (66)
  2. Solid Tumor Oncology Division (50)
  3. Division of Subspecialty Medicine (27)
  4. Survivorship Research (25)
  5. Dermatology Service (21)
  6. Dermatology (21)
  7. Gastrointestinal Oncology Service (14)
  8. Epidemiology and Biostatistics (11)
  9. GSK Faculty (11)
  10. Biostatistics Service (10)
  1. "acne"
Formats
  1. Journal Article (81)
  2. Review (5)
  3. Research Letter (2)
  4. Editorial (1)
  5. Guidelines (1)
  6. Miscellaneous (1)
Groups
  1. Department of Medicine (66)
  2. Solid Tumor Oncology Division (50)
  3. Division of Subspecialty Medicine (27)
  4. Survivorship Research (25)
  5. Dermatology (21)
  6. Dermatology Service (21)

More Groups

People
  1. Mario Lacouture (13)
  2. Leonard Saltz (8)
  3. Allan Halpern (5)
  4. Patricia Myskowski (5)
  5. Vincent Miller (5)
  6. Clifford Hudis (4)

More People

Years
  1. 2025 (3)
  2. 2024 (6)
  3. 2023 (9)
  4. 2022 (1)
  5. 2021 (1)
  6. 2020 (3)

More Years

Publications
  1. Clinical Cancer Research (7)
  2. Journal of Clinical Oncology (7)
  3. Supportive Care in Cancer (5)
  4. The Oncologist (5)
  5. Journal of the American Academy of Dermatology (4)
  6. Gynecologic Oncology (3)

More Publications

Publishers
  1. Elsevier Inc. (9)
  2. Oxford University Press (8)
  3. American Association for Cancer Research (7)
  4. American Society of Clinical Oncology (7)
  5. Mosby Elsevier (5)
  6. Springer (5)

More Publishers

Results (91)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Popularity of infrared saunas and potential dermatologic risks: A Google Trends analysis
    Research Letter

    Pan, S.; Gallo Marin, B.; Ragi, S. D.; Lim, R. K.; O'Connell, K. A.; Libby, T. J.
    Clinics in Dermatology (2023)

    Fulltext@MSK | Save
  • The role of dermocosmetics in the management of cancer-related skin toxicities: International expert consensus
    Review

    Dreno, B.; Khosrotehrani, K.; De Barros Silva, G.; Wolf, J. R.; Kerob, D.; Trombetta, M.; Atenguena, E.; Dielenseger, P.; Pan, M.; Scotte, F.; more...
    Supportive Care in Cancer (2023)

    Fulltext@MSK | Save
  • Dermatologic adverse events in acute lymphocytic leukemia patients treated with bispecific T-cell engager blinatumomab
    Research Letter

    Parisi, R.; Cowen, E. A.; Gu, S.; Dusza, S.; Pulitzer, M.; Geyer, M. B.; King, A. C.; Markova, A.
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: A multicenter analysis
    Journal Article

    Aaroe, A.; Kurzrock, R.; Goyal, G.; Goodman, A. M.; Patel, H.; Ruan, G.; Ulaner, G.; Young, J.; Li, Z.; Dustin, D.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Safety and efficacy of cobimetinib plus atezolizumab in patients with solid tumors: A phase II, open-label, multicenter, multicohort study
    Journal Article

    Sherman, E.; Lee, J. L.; Debruyne, P. R.; Keam, B.; Shin, S. J.; Gramza, A.; Caro, I.; Amin, R.; Shah, K.; Yan, Y.; more...
    ESMO Open (2023)

    Fulltext@MSK | Save
  • Safety and clinical activity of atezolizumab plus erlotinib in patients with non-small-cell lung cancer
    Journal Article

    Rudin, C. M.; Cervantes, A.; Dowlati, A.; Besse, B.; Ma, B.; Costa, D. B.; Schmid, P.; Heist, R.; Villaflor, V. M.; Spahn, J.; more...
    ESMO Open (2023)

    Fulltext@MSK | Save
  • Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for EGFR exon 20 insertion–positive non–small cell lung cancer
    Review

    Yang, J. C. H.; Zhou, C.; Jänne, P. A.; Ramalingam, S. S.; Kim, T. M.; Riely, G. J.; Spira, A. I.; Piotrowska, Z.; Mekhail, T.; Garcia Campelo, M. R.; more...
    Expert Review of Anticancer Therapy (2023)

    Fulltext@MSK | Save
  • Dermatologic immune-related adverse events to checkpoint inhibitors in cancer
    Editorial

    Shah, N. J.; Lacouture, M. E.
    Journal of Allergy and Clinical Immunology (2023)

    Fulltext@MSK | Save
  • Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: Final results from the BFORE trial
    Journal Article

    Brümmendorf, T. H.; Cortes, J. E.; Milojkovic, D.; Gambacorti-Passerini, C.; Clark, R. E.; le Coutre, P.; Garcia-Gutierrez, V.; Chuah, C.; Kota, V.; Lipton, J. H.; more...
    Leukemia (2022)

    Fulltext@MSK | Save
  • Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines
    Guidelines

    Lacouture, M. E.; Sibaud, V.; Gerber, P. A.; van den Hurk, C.; Fernández-Peñas, P.; Santini, D.; Jahn, F.; Jordan, K.; ESMO Guidelines Committe
    Annals of Oncology (2021)

    Fulltext@MSK | Save